White Paper

Pycnogenol® Normalizes Cardio Risks During Perimenopause

Format: PDF file | Document type: White Paper | Promoted Content

This content is provided by Horphag Research (USA) Inc., and any views and opinions expressed do not necessarily reflect those of www.nutraingredients-usa.com


A new study builds upon previous research showing the benefits of Pycnogenol®​ for alleviating perimenopause symptoms and is the first study to show effects on cardiovascular risk markers, homocysteine and CRP levels.

Daily Pycnogenol®​ supplementation reduced and normalized elevated cardiovascular risk factors often related to perimenopause: cholesterol, triglycerides, blood pressure and blood glucose. Participants also reported significant relief of hot flashes, reduction of night sweats and mood improvement.